Multisystem Inflammatory Syndrome in Children (MIS-C) versus Kawasaki Disease: A Never-ending Spectrum of Phenotypes.

[1]  B. McCrindle,et al.  Kawasaki Disease in the Time of COVID-19 and MIS-C – The International Kawasaki Disease Registry , 2023, Canadian Journal of Cardiology.

[2]  E. Karabulut,et al.  The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study , 2023, Children.

[3]  M. J. Campbell,et al.  Multisystemic Inflammatory Syndrome in Children and Kawasaki Disease: Parallels in Pathogenesis and Treatment , 2023, Current allergy and asthma reports.

[4]  B. McCrindle,et al.  COVID-19 Positive Versus Negative Complete Kawasaki Disease: A Study from the International Kawasaki Disease Registry , 2023, Pediatric Cardiology.

[5]  B. McCrindle,et al.  Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in Children , 2023, Canadian Journal of Cardiology.

[6]  D. McGonagle,et al.  Immune and non-immune mechanisms that determine vasculitis and coronary artery aneurysm topography in Kawasaki disease and MIS-C. , 2022, Autoimmunity reviews.

[7]  S. Özen,et al.  The Characteristics of Patients With COVID‐19–Associated Pediatric Vasculitis: An International, Multicenter Study , 2022, Arthritis & rheumatology.

[8]  Yujia Wang,et al.  Similarities and differences between MIS-C and KD: a systematic review and meta-analysis , 2022, Pediatric Rheumatology.

[9]  B. McCrindle,et al.  Differentiation of Multi-system Inflammatory Syndrome Associated with COVID-19 Versus Kawasaki Disease Using Cardiac Biomarkers , 2022, Canadian Journal of Cardiology.

[10]  B. McCrindle,et al.  Management of Multisystem Inflammatory Syndrome in Children: Decision-Making Regarding a New Condition in the Absence of Clinical Trial Data , 2022, Canadian Journal of Cardiology.

[11]  S. Ozen,et al.  COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis , 2022, Seminars in Arthritis and Rheumatism.

[12]  M. Askenazi,et al.  Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19 , 2022, Nature Medicine.

[13]  L. Henderson,et al.  American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3 , 2022, Arthritis & rheumatology.

[14]  A. Bhutta,et al.  Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis , 2021, PloS one.

[15]  S. Lane,et al.  Cardiac pathology and outcomes vary between Kawasaki disease and PIMS-TS. , 2021, Clinical immunology.

[16]  B. McCrindle,et al.  Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome , 2021, Canadian Journal of Cardiology.

[17]  M. Juan,et al.  Similarities and differences between the immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome and Kawasaki disease. , 2021, The Journal of clinical investigation.

[18]  P. Theocharis,et al.  Hyperinflammatory shock in children during COVID-19 pandemic , 2020, The Lancet.

[19]  Mindy S Lo.  A framework for understanding Kawasaki disease pathogenesis. , 2020, Clinical immunology.

[20]  O. Benada,et al.  Morphology of the vasa vasorum in coronary arteries of the porcine heart: A new insight. , 2019, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[21]  B. McCrindle,et al.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.

[22]  G. Keskindemirci,et al.  Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome and coronary artery dilatation misdiagnosed as Kawasaki disease. , 2015, The Turkish journal of pediatrics.

[23]  I. Koné-Paut,et al.  Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis. , 2014, Joint, bone, spine : revue du rhumatisme.

[24]  B. Vaidyanathan,et al.  Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review , 2013, Rheumatology International.

[25]  Y. Zu,et al.  The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease , 2010, Clinical and experimental immunology.

[26]  R. Yeung.  Kawasaki disease: update on pathogenesis , 2010, Current opinion in rheumatology.

[27]  A. Barger,et al.  Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.

[28]  Y. Sakurai,et al.  Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease. , 2010, Journal of investigational allergology & clinical immunology.